Sputum and endotracheal aspirates (ETs) are not among the vendor-approved specimens for the Cepheid Xpert SARS-CoV-2 assay. However, they are the common lower respiratory tract specimens submitted for laboratory diagnosis. Testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in lower respiratory tract samples is required for the discharge of patients from coronavirus disease (COVID) units at some institutions. We developed a protocol used for testing unliquified viscous sputum or tracheal aspirate with the Cepheid Xpert SARS-CoV-2 assay.
All Keywords
【저자키워드】 SARS-CoV-2, rapid detection, sputum, Cepheid Xpert Xpress, endotracheal aspirate, 【초록키워드】 coronavirus disease, coronavirus, protocol, Diagnosis, discharge, Laboratory, COVID, Testing, Patient, Cepheid, Lower respiratory tract, acute respiratory syndrome, specimen, required, submitted, tracheal, 【제목키워드】 protocol, Cepheid, development,
【저자키워드】 SARS-CoV-2, rapid detection, sputum, Cepheid Xpert Xpress, endotracheal aspirate, 【초록키워드】 coronavirus disease, coronavirus, protocol, Diagnosis, discharge, Laboratory, COVID, Testing, Patient, Cepheid, Lower respiratory tract, acute respiratory syndrome, specimen, required, submitted, tracheal, 【제목키워드】 protocol, Cepheid, development,